Promega, Expertise Partner
We share your passion for science. Promega is committed to excellence in providing simple and high-quality assays for high-throughput screening and small molecule and biologics drug discovery. Solutions include best-in-class assays for Kinase inhibitor screening, cell health (CellTiter-Glo, Caspase-Glo and RealTime-Glo Cell Viability & Apoptosis) and energy metabolism; innovative protein reporter technologies (NanoBRET Target Engagement, PPI, CRISPR-mediated protein tagging with HiBiT and easy to use bioluminescent immunoassays) and high-throughput nucleic acid chemistry. Let’s collaborate.
Burning Rock Biotech, Innovation Partner
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 185,000 tissue and liquid-based tests completed cumulatively, and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
IntoDNA, Event Partner
IntoDNA is a service provider that delivers its technology STRIDE for super-sensitive, direct, in situ DNA damage detection combined with a set of comprehensive solutions and expertise to support customers and projects within the area of precision medicine that develop DDR targeted therapies. IntoDNA provides tools that can be applied in cells and tissue samples.
Learn more how you can enrich your research and drug development process with precise DNA damage analysis: